← Leaderboards
Jeanne A Drisko
University Of Kansas Medical Center
$478,818
Attributed
$478,818
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $424K · FY2007–09$500K$375K$250K$125K$0
'07
'08
'09
Funding mix
By agency
NIH$478,818 · 5
By mechanism
M01$478,818 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Kansas Medical Center
Same institution · by research overlap
- Shilpa J Buch$35,602,348
- Navneet Kaur Dhillon$8,934,291
- Peter G Smith$13,917,963
- Carol J Fabian$11,007,875
- Ann M Davis$9,011,995
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingResearch PersonnelResourcesSourceUnited States National Institutes Of HealthInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseGrantAbstractingPilot ProjectsEvaluationHormonesMenopauseSafetyVitaminsAntioxidantsClinical ResearchDouble-Blind MethodDrug KineticsIntravenousMalignant Neoplasm Of PancreasOncologyPlacebo ControlPurpose
Grant awards (5)
BIOIDENTICAL HORMONES IN MENOPAUSE$29,919
M01 · FY2009 · RR · contact PI
BIOIDENTICAL HORMONES IN MENOPAUSE$24,932
M01 · FY2008 · RR · contact PI
EFFICACY OF ANTIOXIDANT USE IN PANCREATIC CANCER$252,714
M01 · FY2007 · RR · contact PI
DOUBLE BLIND PLACEBO CONTROLLED EVALUATION OF BIOIDENTICALHORMONES$95,115
M01 · FY2007 · RR · contact PI
PHARMACOKINETIC EVALUATION OF INTRAVENOUS VITAMIN C IN ONCOLOGY PATIENTS$76,138
M01 · FY2007 · RR · contact PI